CRP and necrotizing enterocolitis: Unlike many other advanced biomarkers, CRP and albumin testing are widely available, cost-effective, and can be routinely performed for early risk stratification in NEC, facilitating timely recognition of disease progression, earlier surgical intervention when needed, and, ultimately, improved neonatal outcomes.